Director · MADRIGAL PHARMACEUTICALS, INC. · MADRIGAL PHARMACEUTICALS, INC. — Stock Option (Right to Buy)
Side
M
Value
—
Shares
280
Price
—
Executed
Jan 9, 2026
Disclosed
Jan 13, 2026
Disclosure timeline4 days from execution to publication · legal deadline 2 business days
Jan 9 executedJan 13, 2026 disclosed
MDGL · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Option exercise — administrative, little informational value
Relative size+1 / 25
No reported dollar value · new position
Filing timing0 / 15
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
Pre-arranged plan-10
Executed under a Rule 10b5-1 trading plan
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
MADRIGAL PHARMACEUTICALS, INC. — Stock Option (Right to Buy)
Ticker
MDGL
Shares
280
Price per share
$0
Execution date (reported)
Jan 9, 2026
Owned after transaction
0 shares
Rule 10b5-1 plan
Yes, as checked by the filer
Days from execution to publication
4
What this establishes
Friedman Paul A filed this Form 4 reporting a option exercise of MDGL on Jan 9, 2026. It became public on Jan 13, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director
Friedman Paul Acik:0001236927
Issuer
MADRIGAL PHARMACEUTICALS, INC.cik:0001157601
Revision history · 0
No field has changed since this record was first ingested.
